Active Secondary Progressive Multiple Sclerosis (SPMS)
Also known as: Active secondary progressive Multiple Sclerosis
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB08908 | Dimethyl fumarate | A medication used to treat patients with the relapsing-remitting form of multiple sclerosis. |
| DB14783 | Diroximel fumarate | A drug used for the treatment of relapsing forms of Multiple Sclerosis (MS). |
| DB08868 | Fingolimod | A sphingosine 1-phosphate receptor modulator used to treat patients with the relapsing-remitting form of multiple sclerosis (MS) and studied to manage lung complications of COVID-19. |
| DB05259 | Glatiramer | An immunomodulator used to reduce the frequency of relapses in Multiple Sclerosis (MS). |
| DB11988 | Ocrelizumab | A CD20 specific monoclonal antibody used to treat relapsing remitting multiple sclerosis. |
| DB06650 | Ofatumumab | An anti-CD20 antibody used for the treatment of chronic lymphocytic leukemia (CLL) in selected patients with certain treatment histories and responsiveness to anticancer medications. |
| DB12612 | Ozanimod | A sphingosine 1-phosphate receptor modulator being studied to treat Multiple Sclerosis (MS) and inflammatory bowel disease (IBD). |
| DB12016 | Ponesimod | A sphingosine 1-phosphate receptor modulator indicated to treat relapsing multiple sclerosis. |
| DB11850 | Ublituximab | A low-fucose CD20-targeted monoclonal antibody used in the treatment of relapsing forms of multiple sclerosis. |
| Drug | Drug Name | Phase | Status | Count |
|---|